- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06545968
A Social Media Intervention to Improve Retention in Care for Adolescents and Young Adults With HIV in Uganda (REMAIN)
Retention Through mHealth for Adolescents and Young Adults With HIV in Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Julian Adong, MMed
- Phone Number: +256 755553595
- Email: jadong@must.ac.ug
Study Locations
-
-
-
Mbarara, Uganda
- Recruiting
- Mbarara University of Science and Technology
-
Contact:
- Julian Adong, MMed
- Phone Number: +256 755553595
- Email: jadong@must.ac.ug
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
The eligibility criteria is as follows:
For adolescents and young adults with HIV (AYWH)
- AYWH who are aged 15-24
- AYWH who are new to care (less than or equal to one month in care), or who are re-engaging in care after being lost to follow up for greater or equal to six months.
- Fluent in English or Runyankole (the local language)
- For aim 3, AYWH who have access (own or shared) to a smartphone
Exclusion criteria for AYWH 1) Inability to provide consent
For counsellors Inclusion criteria
- Clinic counsellors who are ≥18 years
- Clinic counsellors who have worked at the HIV clinic for ≥ 1 year
Exclusion criteria
1) Inability to provide consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
These are the participants who will be randomised to receive the intervention at the start of the study.
|
WatsApp-based modules to influence retention in care behaviour
|
|
No Intervention: Wait list control arm
These are participants who will not receive the intervention initially, but will move to the intervention arm after 6 months of follow-up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary intervention outcome will be the acceptability, feasibility of the intervention.
Time Frame: 12 months
|
Acceptability will be measured using the Acceptability of Intervention Measure (AIM) and will be considered acceptable if ≥70% (35/50) of intervention participants rate all 4 items on the AIM (a 5-point Likert scale) as "agree" or higher. The intervention will be considered feasible if ≥70% (35/50) of intervention participants rate all 4 items on the Feasibility of Intervention Measure (FIM), (a 5-point Likert scale) as "agree" or higher. |
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention
Time Frame: 12 months
|
The secondary outcome of the intervention will be retention in care, which will be assessed at the end of 12 months.
This will be defined as the proportion of participants active in care (i.e have not missed a scheduled appointment in the last 12 months) The investigators will compare the proportion of participants actively engaged in care in the immediate intervention and the deferred intervention arm.
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Julian Adong, MMed, Mbarara University of Science and Technology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MUST-2024-06-14
- K43TW012640 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent Behavior
-
World Health OrganizationLondon School of Hygiene and Tropical Medicine; University of Ghana; Biomedical... and other collaboratorsRecruitingHealth-Related Behavior | Adolescent Behavior | Adolescent Development | Health Care Seeking BehaviorGhana, Tanzania, Zimbabwe
-
University of CoimbraRecruitingAdolescent Behavior | Adolescent - Emotional ProblemPortugal
-
University of North Carolina, Chapel HillNot yet recruitingAdolescent BehaviorUnited States
-
Seattle Children's HospitalRecruiting
-
Karabuk UniversityCompleted
-
Centerstone Research InstituteActive, not recruitingRisk Reduction | Adolescent Behavior | Adolescent Problem BehaviorUnited States
-
Child TrendsUniversity of California, San Francisco; Power to DecideRecruiting
-
The University of Texas Medical Branch, GalvestonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Child TrendsUniversity of Maryland; Identity, Inc.Completed
-
Stanford UniversityRecruitingAdolescent BehaviorUnited States
Clinical Trials on A social media based intervention
-
University of California, Los AngelesBrown University; Asociación Civil Impacta Salud y Educación, Peru; The Fenway...Completed
-
The First Hospital of Hebei Medical UniversityCompleted
-
University of LouisvilleNational Institute of Nursing Research (NINR)Completed
-
Saglik Bilimleri UniversitesiNot yet recruiting
-
University of California, San FranciscoNational Cancer Institute (NCI); HopeLab Foundation; Rescue AgencyRecruitingNicotine Dependence | Vaping | Vaping CessationUnited States
-
University of MichiganNational Institute on Drug Abuse (NIDA)Completed
-
National Chung Hsing UniversityCompletedPhysical Activity | SleepTaiwan
-
University of California, IrvineNational Institute of Mental Health (NIMH); University of California, Los AngelesCompleted
-
University of California, San DiegoNational Institute of Nursing Research (NINR); Brown UniversityCompleted
-
The University of Hong KongLok Sin Tong Benevolent Society, KowloonCompleted